EARS - Auris Medical Holding Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
3,036
6,690
19,211
24,777
26,536
Selling General and Administrative
4,393
4,265
5,150
5,412
4,342
Total Operating Expenses
7,645
10,954
24,361
30,223
30,878
Operating Income or Loss
-7,645
-10,954
-24,361
-30,223
-30,878
Interest Expense
239
1,070
1,640
829
8
Total Other Income/Expenses Net
-2,474
690
1,521
191
1,144
Income Before Tax
-10,357
-11,334
-24,427
-30,793
-29,705
Income Tax Expense
-82
162
-18
-131
0
Income from Continuing Operations
-10,276
-11,496
-24,409
-30,662
-29,705
Net Income
-10,276
-11,496
-24,409
-30,662
-29,705
Net Income available to common shareholders
-10,276
-11,496
-24,409
-30,662
-29,705
Reported EPS
Basic
-
-14.40
-112.00
-178.00
-184.00
Diluted
-
-14.40
-112.00
-178.00
-184.00
Weighted average shares outstanding
Basic
-
795
218
172
161
Diluted
-
795
218
172
161
EBITDA
-
-10,264
-22,787
-29,867
-29,697